臓器移植検査の世界市場:血清学的検査、混合リンパ球培養試験(MLC)、ポリメラーゼ連鎖反応(PCR)、次世代シーケンシング(NGS)...市場調査レポートについてご紹介

【英文タイトル】Transplant Diagnostics Market by Technology (Serological, MLC, PCR, NGS), Antigen (HLA Class I & II), Product (Instrument, Reagent, Kits), Application (Diagnostic, Research), End User (Hospitals, Diagnostic Centers, Academia) - Global Forecasts to 2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 GEOGRAPHIC SCOPE 17
1.3.3 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 20
2.1.2.1 Key data from primary sources 21
2.1.2.2 Key industry insights 22
2.1.2.3 Breakdown of Primaries 22
2.2 MARKET SIZE ESTIMATION 23
2.2.1 BOTTOM-UP APPROACH 23
2.2.2 TOP-DOWN APPROACH 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 RESEARCH ASSUMPTIONS 26
2.4.1 ASSUMPTIONS 26

3 EXECUTIVE SUMMARY 27
3.1 INTRODUCTION 27
3.2 HISTORY, EVOLUTION, AND CURRENT SCENARIO 28
3.3 FUTURE OUTLOOK 29
3.4 CONCLUSION 31

4 PREMIUM INSIGHTS 32
4.1 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, 2014–2019 32
4.2 GLOBAL TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET, BY REGION (2014–2019) 33
4.3 TRANSPLANT DIAGNOSTIC PRODUCTS AND SERVICES MARKET, BY REGION (2014) 34
4.4 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER (2014–2019) 35
4.5 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION (2014–2019) 36

5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.2.1 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 38
5.2.2 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT 38
5.2.3 TRANSPLANT DIAGNOSTICS MARKET, BY END USER 39
5.2.4 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 39
5.3 MARKET DYNAMICS 39
5.3.1 DRIVERS 40
5.3.1.1 Rising number of solid organ, soft tissue, and stem cell transplantation procedures 40
5.3.1.2 Technological advancements in HLA typing 41
5.3.1.3 Growing geriatric population 42
5.3.2 RESTRAINTS 43
5.3.2.1 High cost of PCR and NGS instruments 43
5.3.2.2 Huge gap between number of organs donated and required annually 43
5.3.2.3 Limited medical reimbursements available for transplantation procedures 44
5.3.3 OPPORTUNITIES 44
5.3.3.1 Growing market penetration in emerging countries 44
5.3.3.2 Technological shift from serological assays to genome-based HLA profiling 45

6 INDUSTRY TRENDS 47
6.1 INTRODUCTION 47
6.2 VALUE CHAIN ANALYSIS 47
6.3 PORTER’S FIVE FORCES ANALYSIS 48
6.3.1 THREAT FROM NEW ENTRANTS 49
6.3.2 THREAT FROM SUBSTITUTES 50
6.3.3 BARGAINING POWER OF SUPPLIERS 50
6.3.4 BARGAINING POWER OF BUYERS 51
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 51

7 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 52
7.1 INTRODUCTION 53
7.2 MOLECULAR ASSAYS 54
7.2.1 POLYMERASE CHAIN REACTION (PCR)-BASED 56
7.2.1.1 Sequence-specific Primer PCR (SSP-PCR) 56
7.2.1.2 Sequence-specific oligonucleotide PCR (SSO-PCR) 57
7.2.2 SEQUENCING-BASED ASSAYS 58
7.2.2.1 Sanger sequencing 59
7.2.2.2 Next-generation sequencing (NGS) 59

7.3 NON-MOLECULAR ASSAYS 60
7.3.1 SEROLOGICAL ASSAYS 62
7.3.2 MIXED LYMPHOCYTE CULTURE (MLC) ASSAYS 63

8 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 65
8.1 INTRODUCTION 66
8.2 REAGENTS AND CONSUMABLES 67
8.3 INSTRUMENTS 68
8.4 SOFTWARE AND SERVICES 69

9 TRANSPLANT DIAGNOSTICS MARKET, BY END USER 71
9.1 INTRODUCTION 72
9.2 HOSPITALS AND TRANSPLANT CENTERS 73
9.3 COMMERCIAL SERVICE PROVIDERS 74
9.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 75

10 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 77
10.1 INTRODUCTION 78
10.2 DIAGNOSTIC APPLICATIONS 79
10.3 RESEARCH APPLICATIONS 80

11 TRANSPLANT DIAGNOSTICS MARKET, BY REGION 81
11.1 INTRODUCTION 82
11.2 NORTH AMERICA 83
11.2.1 U.S. 84
11.2.2 CANADA 86
11.3 EUROPE 88
11.3.1 GERMANY 89
11.3.2 U.K. 91
11.3.3 FRANCE 93
11.3.4 REST OF EUROPE 94
11.4 ASIA-PACIFIC 97
11.4.1 JAPAN 98
11.4.2 CHINA 100
11.4.3 INDIA 102
11.4.4 REST OF ASIA-PACIFIC 104
11.5 REST OF THE WORLD 106

12 COMPETITIVE LANDSCAPE 108
12.1 OVERVIEW 108
12.2 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 108
12.3 COMPETITIVE SCENARIO 110
12.4 RECENT DEVELOPMENTS 111
12.4.1 MERGERS AND ACQUISITIONS 111
12.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 113
12.4.3 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS 114
12.4.4 GEOGRAPHICAL EXPANSION 115
12.4.5 OTHER DEVELOPMENTS 116

13 COMPANY PROFILES 117
(Overview, Financials, Products & Services, Strategy, & Developments)*
13.1 INTRODUCTION 117
13.2 THERMO FISHER SCIENTIFIC, INC. 120
13.3 IMMUCOR, INC. 125
13.4 OLERUP SSP AB 128
13.5 QIAGEN N.V. 130
13.6 BIO-RAD LABORATORIES, INC. 134
13.7 ABBOTT LABORATORIES, INC. 138
13.8 ILLUMINA, INC. 142
13.9 LINKAGE BIOSCIENCES, INC. 145
13.10 FUJIREBIO EUROPE N.V. 148
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

14 APPENDIX 149
14.1 INSIGHTS OF INDUSTRY EXPERTS 149
14.2 DISCUSSION GUIDE 150
14.3 COMPANY DEVELOPMENTS 154
14.3.1 THERMO FISHER SCIENTIFIC 154
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 155
14.5 AVAILABLE CUSTOMIZATIONS 155
14.6 RELATED REPORTS 156


【レポート販売概要】

■ タイトル:臓器移植検査の世界市場:血清学的検査、混合リンパ球培養試験(MLC)、ポリメラーゼ連鎖反応(PCR)、次世代シーケンシング(NGS)
■ 英文:Transplant Diagnostics Market by Technology (Serological, MLC, PCR, NGS), Antigen (HLA Class I & II), Product (Instrument, Reagent, Kits), Application (Diagnostic, Research), End User (Hospitals, Diagnostic Centers, Academia) - Global Forecasts to 2019
■ 発行日:2015年3月25日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-BT-3266
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。